Skip Nav Destination
Oncogenes and Tumor Suppressors|
November 16, 2008
Evi-1 Is a Direct Target of MLL Oncoproteins in Hematopoietic Stem Cells
Shunya Arai,
Shunya Arai
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Susumu Goyama,
Susumu Goyama
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Munetake Shimabe,
Munetake Shimabe
*
2Hematology and Oncology, Graduate School of Med., Tokyo, Japan
Search for other works by this author on:
Motoshi Ichikawa,
Motoshi Ichikawa
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Yoichi Imai,
Yoichi Imai
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Tsuyoshi Takahashi,
Tsuyoshi Takahashi
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Akira Hangaishi,
Akira Hangaishi
*
1Hematology and Oncology, University of Tokyo, Tokyo, Japan
Search for other works by this author on:
Mineo Kurokawa, MD, PhD
Mineo Kurokawa, MD, PhD
2Hematology and Oncology, Graduate School of Med., Tokyo, Japan
Search for other works by this author on:
Blood (2008) 112 (11): 3807.
Citation
Shunya Arai, Susumu Goyama, Munetake Shimabe, Motoshi Ichikawa, Yoichi Imai, Tsuyoshi Takahashi, Akira Hangaishi, Mineo Kurokawa; Evi-1 Is a Direct Target of MLL Oncoproteins in Hematopoietic Stem Cells. Blood 2008; 112 (11): 3807. doi: https://doi.org/10.1182/blood.V112.11.3807.3807
Download citation file:
November 16 2008
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal